---
title: "Hengxing Science & Technology released its performance for the first half of the year, with a net profit attributable to the parent company of 21.3756 million yuan, a year-on-year increase of 111.08%"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/254947633.md"
description: "According to the Zhitong Finance APP, Hengxing Science & Technology released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 2.436 billion yuan, a year-on-year decrease of 0.67%. The net profit attributable to shareholders of the listed company was 21.3756 million yuan, a year-on-year increase of 111.08%. The net loss attributable to shareholders of the listed company, after deducting non-recurring gains and losses, was 4.6646 million yuan. The basic earnings per share were 0.02 yuan"
datetime: "2025-08-28T08:05:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254947633.md)
  - [en](https://longbridge.com/en/news/254947633.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254947633.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/254947633.md) | [繁體中文](https://longbridge.com/zh-HK/news/254947633.md)


# Hengxing Science & Technology released its performance for the first half of the year, with a net profit attributable to the parent company of 21.3756 million yuan, a year-on-year increase of 111.08%

According to the Zhitong Finance APP, Hengxing Science & Technology (002132.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 2.436 billion yuan, a year-on-year decrease of 0.67%. The net profit attributable to shareholders of the listed company was 21.3756 million yuan, a year-on-year increase of 111.08%. The net loss attributable to shareholders of the listed company, after deducting non-recurring gains and losses, was 4.6646 million yuan. The basic earnings per share were 0.02 yuan

### 相关股票

- [Hengxing Science & Technology (002132.CN)](https://longbridge.com/zh-CN/quote/002132.CN.md)

## 相关资讯与研究

- [Lite-On optimistic about next 2 years of business](https://longbridge.com/zh-CN/news/278420124.md)
- [Viridis’ Colossus Rare Earth Project Joins Brazil’s Climate Investment Platform](https://longbridge.com/zh-CN/news/278453122.md)
- [Trump: They have agreed to quadruple production of "exquisite class" weaponry](https://longbridge.com/zh-CN/news/278164233.md)
- [ZAWYA-PRESSR: Mubadala Bio expands access to critical cardiovascular medications](https://longbridge.com/zh-CN/news/278515357.md)
- [06:47 ETKelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Atopic Dermatitis](https://longbridge.com/zh-CN/news/278376120.md)